Top Markets
Coin of the day
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
주식 순위 #12609
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
주가
$1.29
시가총액
$567.34M
변동 (1일)
-1.33%
변동 (1년)
-20.72%
국가
CN
거래 Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

카테고리

Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)의 주가 이력
최고 종가: $1.30 (2026-08-01 기준)

최저 종가: $1.81 (2016-03-01 기준)
Zhejiang Starry Pharmaceutical Co.,Ltd.의 주가 이력 (2016 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 9.49%
2025 2.59%
2024 -35.49%
2023 -25.23%
2022 -60.98%
2021 -5.21%
2020 140.70%
2019 113.70%
2018 -9.58%
2017 -37.64%
2016 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$171.67 -
DE
$166.36 31.46%
DE
$37.61 25.11%
JP
$222.33 27.49%
CH
$21.22 17.31%
IN